Biofarm (LTS:0HTH) Interest Expense: lei-0.0 Mil (TTM As of Mar. 2026)

What is Biofarm Interest Expense?

Biofarm LTS:0HTH 69 Interest Expense is lei-0.0 Mil as of Mar. 2026. GuruFocus rates LTS:0HTH with a GF Score™ of 69/100 and a GF Value™ of lei0.15. The stock has 6 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Biofarm's interest expense for the three months ended in Mar. 2026 was lei -0.0 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was lei-0.0 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Biofarm's Operating Income for the three months ended in Mar. 2026 was lei 34.2 Mil. Biofarm's Interest Expense for the three months ended in Mar. 2026 was lei -0.0 Mil. Biofarm's Interest Coverage for the quarter that ended in Mar. 2026 was 4,879.57. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Biofarm (LTS:0HTH) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Biofarm's Interest Expense for the three months ended in Mar. 2026 was lei-0.0 Mil. Its Operating Income for the three months ended in Mar. 2026 was lei34.2 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was lei1.1 Mil.

Biofarm's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2026 )	/	Interest Expense (Q: Mar. 2026 )
	=	-1	*	34.157	/	-0.0070000000000001
	=	4,879.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Biofarm SA has enough cash to cover all of its debt. Its financial situation is stable.

Biofarm Interest Expense Historical Data

* Premium members only.

The historical data trend for Biofarm's Interest Expense can be seen below:

Biofarm Interest Expense Chart

Biofarm Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Interest Expense

Get a 7-Day Free Trial

-0.03

-0.04

Biofarm Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Interest Expense	Get a 7-Day Free Trial															-0.01	-0.01	-0.01	-0.01	-0.01

69GF Score

Biofarm SA LTS:0HTH

Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Biofarm Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was lei-0.0 Mil.

Frequently Asked Questions Learn more about Interest Expense →

What does a Interest Expense of lei-0.0 Mil mean?

Biofarm (LTS:0HTH) has a Interest Expense of lei-0.0 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Biofarm and its competitors.

Is Biofarm's Interest Expense too high?

Biofarm's current Interest Expense is lei-0.0 Mil. Overall, Biofarm has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.

How does Biofarm's Interest Expense compare to ZTS and UTHR?

Biofarm's Interest Expense of lei-0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Interest Expense for a Drug Manufacturers company?

A good Interest Expense depends on the Drug Manufacturers industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Interest Expense mean?

A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Biofarm and its competitors. Biofarm's current Interest Expense is lei-0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Biofarm stock overvalued right now?

Biofarm (LTS:0HTH) has a current Interest Expense of lei-0.0 Mil. The stock's GF Value™ is lei0.15, compared to a current price of lei0.24 — trading 58% above its estimated fair value. The current Interest Expense is lei-0.0 Mil. Biofarm's overall GF Score™ is 69/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Interest Expense calculated?

Interest Expense is calculated from a company's financial statements. For Biofarm (LTS:0HTH), the current Interest Expense is lei-0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biofarm (LTS:0HTH) Overvalued in 2026?

Based on GuruFocus' analysis, Biofarm stock appears to be overvalued. The current stock price of lei0.24 is trading 58% above its estimated GF Value™ of lei0.15.

Key valuation signals for LTS:0HTH:

Interest Expense: lei-0.0 Mil
GF Value™: lei0.15 vs. price of lei0.24 (58% above fair value)
GF Score™: 69/100 with 6 warning signs

No single metric tells the full story. See the LTS:0HTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Biofarm Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies BSE:ATB XTER:MRK XSWX:GALD TSE:4502 SHSE:600276 NSE:SUNPHARMA LSE:HLN XTAE:TEVA XSWX:SDZ ZTS UTHR HKSE:03692 VTRS NSE:DIVISLAB OSTO:SOBI NBIX NSE:TORNTPHARM SHSE:688506 XPAR:IPN TSE:4507

Other Exchanges BIO:Romania

Address 99 Logofatul Tautu Street, Sector 3, Bucharest, ROU, 031212

Website https://www.biofarm.ro

Biofarm SA is a company engaged in production and marketing in the pharmaceutical sector. It is involved in the manufacture and wholesale of over-the-counter drugs, prescription medications, and dietary supplements. The firm's product portfolio includes pharmaceutical preparations for the digestive system, musculoskeletal system, immune stimulation, respiratory system, cold & flu symptoms, and venous circulation improvement, as well as multivitamins, antioxidants, antiseptics, disinfectants, and cosmetics, among others. Some of its brands are Triferment, Colebil, Cavit, Anghirol, Clorocalcin, and Bixtonim. Additionally, the company offers services, such as investment in research, promotion, and packaging.

69GF Score

Get the complete analysis for LTS:0HTH

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

lei0.24

Price

lei0.15

GF Value

View LTS:0HTH Analysis

See Interest Expense data for all stocks →